Amneal Pharmaceuticals's operating cash flow per share for the
three
months ended in Dec. 2023 was $0.56.
Amneal Pharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.91.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Amneal Pharmaceuticals was 355.20% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -8.30% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 33.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Amneal Pharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:
AMRX'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -76.5 Med: -6.8 Max: 221.3
Current: -8.3
During the past 8 years, Amneal Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 221.30% per year. The lowest was -76.50% per year. And the median was -6.80% per year.
AMRX's 3-Year OCF Growth Rate is ranked worse than 70.72% of 806
companies
in the Drug Manufacturers industry
Industry Median: 7.75
vs AMRX: -8.30
Amneal Pharmaceuticals Operating Cash Flow per Share Historical Data
The historical data trend for Amneal Pharmaceuticals's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Amneal Pharmaceuticals Annual Data
Trend
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Operating Cash Flow per Share
0.01
2.55
1.59
0.43
1.96
Amneal Pharmaceuticals Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Operating Cash Flow per Share
-0.15
0.92
-0.07
0.51
0.56
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Amneal Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amneal Pharmaceuticals Price-to-Operating-Cash-Flow Distribution
For the Drug Manufacturers industry and Healthcare sector, Amneal Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Amneal Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.
Amneal Pharmaceuticals Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Amneal Pharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.91
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amneal Pharmaceuticals Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Amneal Pharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Amneal Pharmaceuticals (Amneal Pharmaceuticals) Business Description
Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AMRX has been successfully added to your 